ClinicalTrials.govpublic full text
RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT
acute myeloid leukemia, allo-hsct, cell therapy, aml, off-the-shelf cell product, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842446
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.